1292. Deputy Ken O'Flynn asked the Minister for Health whether any maximum financial approval thresholds apply under the treatment abroad scheme before additional senior management or Departmental approval is required. [39194/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
1,428 questions match, newest first.
1293. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has conducted any audit specifically examining value-for-money, expenditure controls or financial governance under the treatment abroad scheme since 2020. [39195/26]
1294. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains data comparing the cost of treatments funded abroad under the treatment abroad scheme against estimated equivalent domestic treatment costs. [39196/26]
1295. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme is currently subject to any formal risk assessment relating to expenditure growth, cost escalation, or dependency on overseas treatment provision. [39197/26]
1296. Deputy Ken O'Flynn asked the Minister for Health whether any external consultancy, economic review, or health technology assessment has been commissioned in relation to expenditure under the treatment abroad scheme since 2020. [39198/26]
1297. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any central register of adverse clinical outcomes, complications, revision procedures, hospital readmissions or patient safety incidents arising from treatments funded under the treatment abroad scheme.; and if she will make a statement on the matter. [39199/26]
1298. Deputy Ken O'Flynn asked the Minister for Health whether the HSE receives any routine post-treatment clinical outcome reports from overseas providers in respect of procedures funded under the treatment abroad scheme. [39200/26]
1299. Deputy Ken O'Flynn asked the Minister for Health whether any structured patient follow-up programme exists for persons returning to Ireland following procedures funded under the treatment abroad scheme. [39201/26]
1300. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has carried out any review of long-term patient outcomes associated with procedures funded under the treatment abroad scheme since 2020. [39202/26]
1301. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money framework exists comparing the clinical outcomes and costs associated with overseas procedures funded under the treatment abroad scheme against equivalent treatment pathways domestically. [39203/26]
1302. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any provider-level performance monitoring system in respect of overseas hospitals or clinics receiving treatment abroad scheme referrals. [39204/26]
1303. Deputy Ken O'Flynn asked the Minister for Health whether any formal patient safety governance framework exists specifically governing procedures funded under the treatment abroad scheme. [39205/26]
1304. Deputy Ken O'Flynn asked the Minister for Health the number of complaints, adverse incident reports, legal claims or clinical governance concerns associated with procedures funded under the treatment abroad scheme since 2020. [39206/26]
1305. Deputy Ken O'Flynn asked the Minister for Health whether the Department has sought legal advice regarding governance and duty-of-care obligations arising from State-funded overseas medical procedures where no structured outcomes monitoring system exists. [39207/26]
1306. Deputy Ken O'Flynn asked the Minister for Health whether the absence of structured clinical outcome monitoring under the treatment abroad scheme has been identified on any Departmental or HSE risk register. [39208/26]
1307. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a category-specific expenditure breakdown for procedures funded under the treatment abroad scheme; and if so, whether gender affirmation surgeries are separately identifiable within those records. [39210/26]
1308. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money assessment has been conducted regarding overseas gender affirmation surgeries funded under the treatment abroad scheme since 2020. [39211/26]
1309. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment, governance review or assurance process has been undertaken specifically relating to overseas gender affirmation surgery approvals under the treatment abroad scheme. [39212/26]
1310. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has ever examined category-specific overseas treatment expenditure under the treatment abroad scheme; and if so, to provide details. [39213/26]
1311. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health receives specialty-specific approval or expenditure data from the treatment abroad scheme during quarterly oversight meetings. [39214/26]
1312. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical governance framework exists governing referrals for overseas gender affirmation surgeries funded through the treatment abroad scheme. [39215/26]
1313. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the total annual number of gender affirmation surgery applications approved under the treatment abroad scheme since 2020, by year. [39216/26]
1314. Deputy Ken O'Flynn asked the Minister for Health whether any post-treatment outcome monitoring or follow-up governance arrangements exist for persons funded for overseas gender affirmation surgeries under the treatment abroad scheme. [39217/26]
1315. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken any national capacity assessment of the public pre-exposure prophylaxis (PrEP) programme since 2024; and if so, if she will provide details of the findings, including identified service gaps, unmet demand, regional pressures and recommended expansion measures. [39272/26]
1316. Deputy Ken O'Flynn asked the Minister for Health the number of persons currently awaiting access to public PrEP services, by clinic and by HSE health region; and whether this figure includes informal, paused or closed waiting lists. [39273/26]